Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomised, DBPC, Multicenter Clinical Trial to Evaluate Efficacy and Safety of Sublingual Immunotherapy in Patients With Rhinitis/Rhinoconjunctivitis With or Without Mild to Moderate Asthma, Allergic to Dpt and/or Df

NCT07348302 is registered in ClinicalTrials.gov with Inmunotek S.L. as lead sponsor.

NCT NCT07348302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07348302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomised, DBPC, Multicenter Clinical Trial to Evaluate Efficacy and Safety of Sublingual Immunotherapy in Patients With Rhinitis/Rhinoconjunctivitis With or Without Mild to Moderate Asthma, Allergic to Dpt and/or Df
Lead sponsor
Inmunotek S.L.
Phase
Phase 3
Overall status
Recruiting
Start date
April 2, 2025
Completion date
July 31, 2029
Enrollment
736 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

rhinitis, rhinoconjunctivitis